| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1985) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | ZG7E5POY8O |
| Parent Compound: | BUPROPION |
Structure
| InChI Key | HEYVINCGKDONRU-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C13H19Cl2NO |
| Molecular Weight | 276.21 |
| AlogP | 3.3 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 29.1 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 16.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 1230 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Depressive Disorder | 4 | D003866 | ClinicalTrials |
| Mood Disorders | 4 | D019964 | ClinicalTrials |
| Bipolar Disorder | 3 | D001714 | ClinicalTrials |
| Tobacco Use Disorder | 3 | D014029 | ClinicalTrials |
| Smoking Cessation | 3 | D016540 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Bipolar Disorder | 3 | D001714 | ClinicalTrials |
| Obesity | 2 | D009765 | ClinicalTrials |
| Alcoholism | 2 | D000437 | ClinicalTrials |
| Feeding and Eating Disorders | 2 | D001068 | ClinicalTrials |
| Hepatolenticular Degeneration | 1 | D006527 | ClinicalTrials |
Related Entries
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 3220 |
| ChEMBL | CHEMBL1698 |
| EPA CompTox | DTXSID6044561 |
| FDA SRS | ZG7E5POY8O |
| PubChem | 62884 |
| SureChEMBL | SCHEMBL41602 |
CONTENTS